Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WIL Research, Three S Japan in Services Deal | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

WIL Research, Three S Japan in Services Deal

Expands portfolio of safety assessment services to the Japanese market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WIL Research is partnering with Three S Japan to represent its full portfolio of global safety assessment services in Japan. WIL Research offers technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry, and formulation services. Three S Japan will represent these services through its extensive network of clients in the pharmaceutical and chemical industries.
 
“Three S Japan has a strong reputation serving the country’s pharmaceutical industry with high quality regulatory services underpinned by exceptional client focus,” said David Spaight, chairman and chief executive officer of WIL Research. “Through this partnership, clients will benefit from direct access to staff that can harness the full portfolio of WIL Research’s global services.”
 
Koichi Hagita, chief executive officer and president of Three S Japan, said, “WIL Research’s excellent reputation and our long-term client relationships and regulatory experience in the Japanese market will boost both our companies’ potential for growth.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics